Onco-Innovations Limited (CSE:ONCO)

Canada · Delayed Price · Currency is CAD

1.440

+0.020 (1.41%)

Apr 24, 2025, 2:13 PM EDT

Onco-Innovations Income Statement

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Selling, General & Admin	0.06	0
Operating Expenses	0.06	0
Operating Income	-0.06	-0
Pretax Income	-0.06	-0
Net Income	-0.06	-0
Net Income to Common	-0.06	-0
Shares Outstanding (Basic)	0	-
Shares Outstanding (Diluted)	0	-
EPS (Basic)	-0.13	-
EPS (Diluted)	-0.13	-
EBIT	-0.06	-0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.